Hiperplàsia benigna de pròstata (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hiperplàsia benigna de pròstata" in Catalan language version.

refsWebsite

Global rank Catalan rank

19nih.gov

4^th place

7^th place

11doi.org

2^nd place

6^th place

1worldcat.org

5^th place

1jamanetwork.com

2,650^th place

3,376^th place

1aemps.gob.es

low place

932^nd place

1nejm.org

2,374^th place

2,440^th place

1cochranelibrary.com

low place

aemps.gob.es

«Centro de Información online de Medicamentos de la AEMPS - CIMA». Madrid: AEMPS. Ministerio de Sanidad, Servicios Sociales e Igualdad, 2024.

cochranelibrary.com

Wilt, TJ; Ishani, A; MacDonald, R «Serenoa repens for benign prostatic hyperplasia». Cochrane Library Database Syst Rev, 3, 2002, pàg. CD001423. DOI: 10.1002/14651858.CD001423. PMID: 12137626 [Consulta: 29 desembre 2024].

doi.org

dx.doi.org

Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. «Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010». Lancet, 380, 9859, 2012, pàg. 2163-96. DOI: 10.1016/S0140-6736(12)61729-2. PMC: 6350784. PMID: 23245607 [Consulta: 10 febrer 2023].
Bosch JL, Bohnen AM, Groeneveld FP «Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen Study.». Eur Urol, 46, 6, 2004, pàg. 753-9. DOI: 10.1016/j.eururo.2004.07.019. PMID: 15548443.
Jacobson DJ, St Sauver JL, Parker AS, McGree ME, Sarma AV, Girman CJ et al. «Estimation of prostate size in community-dwelling men». Urology, 77, 2, 2011, pàg. 422-6. DOI: 10.1016/j.urology.2010.05.044. PMC: 3010416. PMID: 20800880 [Consulta: 29 desembre 2024].
Foo, KT «The Role of Transabdominal Ultrasound in Office Urology» (en anglès). Proceedings of Singapore Healthcare, 22, 2, 6-2013, pàg. 125–130. DOI: 10.1177/201010581302200208. ISSN: 2010-1058.
Aprikian S, Luz M, Brimo F, Scarlata E, Hamel L, Cury FL, Tanguay S, Aprikian AG, Kassouf W, Chevalier S «Improving ultrasound-based prostate volume estimation». BMC Urology, 19, 1, 7-2019, pàg. 68. DOI: 10.1186/s12894-019-0492-2. PMC: 6657110. PMID: 31340802.
Nickel JC, Sander S, Moon TD «A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia.». Int J Clin Pract, 62, 10, 2008, pàg. 1547-59. DOI: 10.1111/j.1742-1241.2008.01880.x. PMC: 2658011. PMID: 18822025.
Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z «Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.». JAMA, 296, 19, 2006, pàg. 2319-28. DOI: 10.1001/jama.296.19.2319. PMID: 17105794 [Consulta: 29 gener 2023].
Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ «Finasteride for benign prostatic hyperplasia». Cochrane Database Syst Rev, 10, 2010. DOI: 10.1002/14651858.CD006015.pub3. PMID: 20927745.
Wilt, TJ; Ishani, A; MacDonald, R «Serenoa repens for benign prostatic hyperplasia». Cochrane Library Database Syst Rev, 3, 2002, pàg. CD001423. DOI: 10.1002/14651858.CD001423. PMID: 12137626 [Consulta: 29 desembre 2024].
Wilt, TJ; Ishani, A; Rutks, I; MacDonald, R «Phytotherapy for benign prostatic hyperplasia». Public Health Nutr, 3, 4A, 2000, pàg. 459-72. DOI: 10.1017/s1368980000000549. PMID: 11276294.
Buck, AC; Cox, R; Rees, RW; Ebeling, L; John, A «Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study». Br J Urol, 66, 4, 1990, pàg. 398-404. DOI: 10.1111/j.1464-410x.1990.tb14962.x. PMID: 169962.

jamanetwork.com

Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z «Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.». JAMA, 296, 19, 2006, pàg. 2319-28. DOI: 10.1001/jama.296.19.2319. PMID: 17105794 [Consulta: 29 gener 2023].

nejm.org

Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD et al. «The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.». N Engl J Med, 327, 17, 1992, pàg. 1185-91. PMID: 1383816 [Consulta: 29 gener 2023].

nih.gov

ncbi.nlm.nih.gov

Barry MJ, Fowler FJ Jr, O'Leary MP, et al «The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association». J Urol, 148, 5, 1992, pàg. 1549-57. PMID: 1279218.
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. «Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010». Lancet, 380, 9859, 2012, pàg. 2163-96. DOI: 10.1016/S0140-6736(12)61729-2. PMC: 6350784. PMID: 23245607 [Consulta: 10 febrer 2023].
Roehrborn CG, Girman CJ, Rhodes T, Hanson KA, Collins GN, Sech SM et al. «Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound.». Urology, 49, 4, 1997, pàg. 548-57. PMID: 9111624.
Bosch JL, Bohnen AM, Groeneveld FP «Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen Study.». Eur Urol, 46, 6, 2004, pàg. 753-9. DOI: 10.1016/j.eururo.2004.07.019. PMID: 15548443.
Roehrborn, CG «Accurate determination of prostate size via digital rectal examination and transrectal ultrasound». Urology, 51, 4, 1998, pàg. 19-22. PMID: 9586592.
Jacobson DJ, St Sauver JL, Parker AS, McGree ME, Sarma AV, Girman CJ et al. «Estimation of prostate size in community-dwelling men». Urology, 77, 2, 2011, pàg. 422-6. DOI: 10.1016/j.urology.2010.05.044. PMC: 3010416. PMID: 20800880 [Consulta: 29 desembre 2024].
McNeill SA, Hargreave TB, Geffriaud-Ricouard C, Santoni J, Roehrborn CG «Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin.». Urology, 57, 3, 2001, pàg. 459-65. PMID: 11248620.
Aprikian S, Luz M, Brimo F, Scarlata E, Hamel L, Cury FL, Tanguay S, Aprikian AG, Kassouf W, Chevalier S «Improving ultrasound-based prostate volume estimation». BMC Urology, 19, 1, 7-2019, pàg. 68. DOI: 10.1186/s12894-019-0492-2. PMC: 6657110. PMID: 31340802.
Nickel JC, Sander S, Moon TD «A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia.». Int J Clin Pract, 62, 10, 2008, pàg. 1547-59. DOI: 10.1111/j.1742-1241.2008.01880.x. PMC: 2658011. PMID: 18822025.
Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z «Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.». JAMA, 296, 19, 2006, pàg. 2319-28. DOI: 10.1001/jama.296.19.2319. PMID: 17105794 [Consulta: 29 gener 2023].
AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis y recomendaciones de tratamientos. J Urol 170 (2 Pt 1): 530-47. PMID: 12853821
Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD et al. «The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.». N Engl J Med, 327, 17, 1992, pàg. 1185-91. PMID: 1383816 [Consulta: 29 gener 2023].
Kaplan SA, McConnell JD, Roehrborn CG, et al «Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater». J Urol, 175, 1, 2006, pàg. 217-20. PMID: 16406915.
Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ «Finasteride for benign prostatic hyperplasia». Cochrane Database Syst Rev, 10, 2010. DOI: 10.1002/14651858.CD006015.pub3. PMID: 20927745.
McVary KT, Monnig W, Camps JL Jr, et al «Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial». J Urol, 177, 3, 2007, pàg. 1071-7. PMID: 17296414.
Wilt, TJ; Ishani, A; MacDonald, R «Serenoa repens for benign prostatic hyperplasia». Cochrane Library Database Syst Rev, 3, 2002, pàg. CD001423. DOI: 10.1002/14651858.CD001423. PMID: 12137626 [Consulta: 29 desembre 2024].
Wilt, TJ; Ishani, A; Rutks, I; MacDonald, R «Phytotherapy for benign prostatic hyperplasia». Public Health Nutr, 3, 4A, 2000, pàg. 459-72. DOI: 10.1017/s1368980000000549. PMID: 11276294.
Buck, AC; Cox, R; Rees, RW; Ebeling, L; John, A «Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study». Br J Urol, 66, 4, 1990, pàg. 398-404. DOI: 10.1111/j.1464-410x.1990.tb14962.x. PMID: 169962.

pmc.ncbi.nlm.nih.gov

Jacobson DJ, St Sauver JL, Parker AS, McGree ME, Sarma AV, Girman CJ et al. «Estimation of prostate size in community-dwelling men». Urology, 77, 2, 2011, pàg. 422-6. DOI: 10.1016/j.urology.2010.05.044. PMC: 3010416. PMID: 20800880 [Consulta: 29 desembre 2024].

worldcat.org

Foo, KT «The Role of Transabdominal Ultrasound in Office Urology» (en anglès). Proceedings of Singapore Healthcare, 22, 2, 6-2013, pàg. 125–130. DOI: 10.1177/201010581302200208. ISSN: 2010-1058.